iZafe

Dosell has been awarded sub-contract B, relating to a basic medication dispensing device, where the company’s solution has been evaluated as meeting high standards in terms of functionality, user-friendliness and quality.

The agreement is a framework agreement enabling successive call-offs from both the region and municipalities. The agreement entered into force on April 1, 2026, and runs for an initial period of two years, with the possibility of extension up to a total of four years. As a framework agreement, no volumes are guaranteed, and demand is realized through ongoing call-offs during the contract period.

“This is a strategically important award for us. The fact that an entire region together with its municipalities chooses to procure within a common structure creates strong conditions for broad and gradual implementation over time. It confirms that Dosell meets the requirements of modern healthcare and strengthens our position as a leading player in the field,” says Anders Segerström, CEO of iZafe Group.

The total estimated value of the procurement amounts to approximately SEK 55 million, with a maximum ceiling value of SEK 82.5 million. No allocation of value between the different sub-contract areas has been specified.

The award strengthens iZafe Group’s presence in the Swedish market and establishes an important platform for continued growth and rollout of Dosell within public healthcare and social care.